S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Clinical trial NCT02562716 · COMPLETED
Trial details
- NCT number
- NCT02562716
- Sponsor
- SWOG Cancer Research Network
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-06
- Primary completion
- 2020-05-31
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.